Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Feltgen

Showing results (91-100 of 179) with videos related to

Pageof 18
Sort By:
Investigative Ophthalmology & Visual Science|January 10, 2020
Author Response: Chemical Considerations Regarding the H-Value Methodology and Its Relation With Toxicity DeterminationDirk-Henning Menz, Nicolas Feltgen, Thorsten Lechner, et al.
Scientific Reports|December 17, 2021
Predicting the individual probability of macular hole closure following intravitreal ocriplasmin injections for vitreomacular traction release using baseline characteristicsThomas Bertelmann, Lars Berndzen, Thomas Raber, et al.
Investigative Ophthalmology & Visual Science|April 8, 2026
Microvascular Properties of Dissociated Optic Nerve Fiber Layer (DONFL) After Internal Limiting Membrane PeelingMichael Grün, Jacoba Hofmann, Josep Callizo, et al.
Investigative Ophthalmology & Visual Science|October 23, 2018
How to Ward Off Retinal Toxicity of Perfluorooctane and Other Perfluorocarbon Liquids?Dirk-Henning Menz, Nicolas Feltgen, Helge Menz, et al.
Translational Vision Science & Technology|June 8, 2019
Hydrofluoric Acid and Other Impurities in Toxic Perfluorooctane BatchesDirk-Henning Menz, Nicolas Feltgen, Thorsten Lechner, et al.
Frontiers in Medicine|July 30, 2024
Transforming the future of ophthalmology: artificial intelligence and robotics' breakthrough role in surgical and medical retina advances: a mini reviewEleftherios Chatzimichail, Nicolas Feltgen, Lorenzo Motta, et al.
American Journal of Ophthalmology Case Reports|August 26, 2020
There is no intraocular affection on a SARS-CoV-2 - Infected ocular surfacePeer Lauermann, Marcus Storch, Michael Weig, et al.
Die Ophthalmologie|July 8, 2024
[Aflibercept in a real-world setting: the AURIGA study : 24-month results of the German cohort of treatment-naïve patients with macular edema following retinal vein occlusion receiving intravitreal aflibercept]Joachim Wachtlin, Hakan Kaymak, Hans Hoerauf, et al.
Klinische Monatsblatter Fur Augenheilkunde|November 27, 2019
[Clinical Decision Making for Treatment of Diabetic Macular Oedema with DEX Implant: a Consensus Paper]Albert J Augustin, Nicolas Feltgen, Christos Haritoglou, et al.
Die Ophthalmologie|February 8, 2023
[Ocular alterations in patients with Alport syndrome-An update]Kristina Pfau, Oliver Gross, Sebastian Bemme, et al.
Pageof 18

Showing results (91-100 of 179) with videos related to

Sort By:
Pageof 18
Investigative Ophthalmology & Visual Science|January 10, 2020
Author Response: Chemical Considerations Regarding the H-Value Methodology and Its Relation With Toxicity DeterminationDirk-Henning Menz, Nicolas Feltgen, Thorsten Lechner, et al.
Scientific Reports|December 17, 2021
Predicting the individual probability of macular hole closure following intravitreal ocriplasmin injections for vitreomacular traction release using baseline characteristicsThomas Bertelmann, Lars Berndzen, Thomas Raber, et al.
Investigative Ophthalmology & Visual Science|April 8, 2026
Microvascular Properties of Dissociated Optic Nerve Fiber Layer (DONFL) After Internal Limiting Membrane PeelingMichael Grün, Jacoba Hofmann, Josep Callizo, et al.
Investigative Ophthalmology & Visual Science|October 23, 2018
How to Ward Off Retinal Toxicity of Perfluorooctane and Other Perfluorocarbon Liquids?Dirk-Henning Menz, Nicolas Feltgen, Helge Menz, et al.
Translational Vision Science & Technology|June 8, 2019
Hydrofluoric Acid and Other Impurities in Toxic Perfluorooctane BatchesDirk-Henning Menz, Nicolas Feltgen, Thorsten Lechner, et al.
Frontiers in Medicine|July 30, 2024
Transforming the future of ophthalmology: artificial intelligence and robotics' breakthrough role in surgical and medical retina advances: a mini reviewEleftherios Chatzimichail, Nicolas Feltgen, Lorenzo Motta, et al.
American Journal of Ophthalmology Case Reports|August 26, 2020
There is no intraocular affection on a SARS-CoV-2 - Infected ocular surfacePeer Lauermann, Marcus Storch, Michael Weig, et al.
Die Ophthalmologie|July 8, 2024
[Aflibercept in a real-world setting: the AURIGA study : 24-month results of the German cohort of treatment-naïve patients with macular edema following retinal vein occlusion receiving intravitreal aflibercept]Joachim Wachtlin, Hakan Kaymak, Hans Hoerauf, et al.
Klinische Monatsblatter Fur Augenheilkunde|November 27, 2019
[Clinical Decision Making for Treatment of Diabetic Macular Oedema with DEX Implant: a Consensus Paper]Albert J Augustin, Nicolas Feltgen, Christos Haritoglou, et al.
Die Ophthalmologie|February 8, 2023
[Ocular alterations in patients with Alport syndrome-An update]Kristina Pfau, Oliver Gross, Sebastian Bemme, et al.
Pageof 18